Fennec Pharmaceuticals Inc.
General ticker "FENC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $200.7M (TTM average)
Fennec Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 56.4%.
Estimated limits based on current volatility of 2.2%: low 7.43$, high 7.77$
Factors to consider:
- Total employees count: 29 (-19.4%) as of 2023
- Top business risk factors: Significant losses, Dependence on PEDMARK success, Regulatory and compliance, Supply chain disruptions, Intellectual property risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.98$, 8.80$]
- 2025-12-31 to 2026-12-31 estimated range: [3.89$, 8.67$]
Financial Metrics affecting the FENC estimates:
- Positive: with PPE of -10000.0 at the end of fiscal year the price was very low
- Positive: -3.60 < Operating profit margin, % of 5.40
- Positive: Operating cash flow per share per price, % of 16.19 > 13.24
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of -13.06 <= 18.93
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Negative: Return on assets ratio (scaled to [-100,100]) of -0.96 <= 1.87
Short-term FENC quotes
Long-term FENC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.53MM | $21.25MM | $47.54MM |
| Operating Expenses | $24.12MM | $34.02MM | $44.97MM |
| Operating Income | $-22.59MM | $-12.77MM | $2.57MM |
| Non-Operating Income | $-0.76MM | $-3.20MM | $-2.64MM |
| Interest Expense | $0.98MM | $3.39MM | $4.07MM |
| R&D Expense | $3.53MM | $0.06MM | $0.31MM |
| Income(Loss) | $-23.35MM | $-15.97MM | $-0.07MM |
| Taxes | $0.00MM | $0.00MM | $0.36MM |
| Profit(Loss)* | $-22.41MM | $-16.05MM | $-0.44MM |
| Stockholders Equity | $-2.57MM | $-11.62MM | $-5.87MM |
| Inventory | $0.58MM | $2.16MM | $1.06MM |
| Assets | $26.94MM | $26.86MM | $44.95MM |
| Operating Cash Flow | $-18.06MM | $-17.14MM | $26.98MM |
| Financing Cash Flow | $20.73MM | $6.64MM | $-13.62MM |
| Earnings Per Share** | $-0.85 | $-0.60 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.